About Imad Libbus
Imad Libbus is the chief scientific officer of SymKardia. He is responsible for the company's pre-clinical and clinical research program. SymKardia is developing selective cardiac neuromodulation to treat cardiac arrhythmias.
Before SymKardia, he held technical leadership roles at several medical technology companies. He was an R&D fellow at LivaNova, formerly Cyberonics. He was a senior director at Corventis, which Medtronic acquired. He was a principal research scientist at Boston Scientific, formerly Guidant Corporation. He holds a BSE in biomedical engineering from Duke University, plus an MSE and PhD from Case Western Reserve University. He is an inventor with over 280 issued U.S. patents.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Imad Libbus in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Imad Libbus works with at each company, as listed on that company's latest Form D.
